Disease | thromboembolism |
Phenotype | C0029456|osteoporosis |
Sentences | 1 |
PubMedID- 20626269 | Background: raloxifene use in postmenopausal women with osteoporosis increases the risk of venous thromboembolic events (vte) 2-fold compared with placebo. |
Page: 1